Fig. 6
From: Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer
Relapse-free and overall survival related to high-amplitude SCNAs in NOTCH3, ZNF536, and PIK3R2. Compared to patients not carrying high copy number gains in NOTCH3, ZNF536, and PIK3R2, patients from both COH (panels A and B) and TCGA (panels C and D) carrying high copy gains in at least one of the three genes showed significantly worse relapse-free survival (panel A and C) and overall survival (panel B and D), respectively